MK-677 and GH/IGF-1 Axis Modulation: Preclinical Mechanism Review

What Is MK-677 (Ibutamoren)?

MK-677, also known as Ibutamoren or by the developmental code L-163,191, is a synthetic non-peptide small molecule. It is classified as an orally active, selective agonist of the growth hormone secretagogue receptor subtype 1a (GHSR-1a). Unlike peptide-based secretagogues that are degraded in the gastrointestinal tract, MK-677's sulfonamide backbone allows oral bioavailability in preclinical settings. It is not FDA-approved for any human or veterinary use.

Researchers looking to buy MK-677 for laboratory investigation can source it as a research-grade compound at BehemothLabz. All products are independently third-party tested, with COA available per batch. Sold strictly for laboratory research only.

Disclaimer: MK-677 (Ibutamoren) is a research compound not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. This product is strictly for laboratory research purposes only.

What Hormones Has MK-677 Been Observed to Modulate in Preclinical Models?

The central research question for this compound is how GHSR-1a activation influences the GH/IGF-1 axis. Preclinical investigational data document the following:

Growth Hormone (GH): In preclinical models, GHSR-1a activation by MK-677 has been observed to stimulate pulsatile GH release from the anterior pituitary. The pulsatile pattern mirrors that of endogenous GH secretion in animal model data.

IGF-1: MK-677 administration in animal models has been observed to elevate circulating IGF-1 levels. Published investigational literature (Sevigny et al., 2008) documents a double-blind randomized study conducted under clinical trial protocols in which MK-677 25 mg administered daily resulted in a 60.1% increase in serum IGF-1 levels at 6 weeks and a 72.9% increase at 12 months — confirming target engagement. However, despite this target engagement, no therapeutic benefit was demonstrated in that study, and MK-677 is not approved for any clinical or human use.

Other pituitary hormones: Some preclinical animal model data suggest MK-677 may also influence ACTH and prolactin levels at higher concentrations, though this is less well-characterized.

MK-677 as a Research Tool: Why the GH/IGF-1 Axis Matters

The GH/IGF-1 axis regulates numerous biological processes in preclinical systems, including muscle protein synthesis, bone mineral density, lipid metabolism, and sleep architecture. MK-677 is used as a probe compound in laboratory research to examine these downstream effects of GH/IGF-1 axis modulation in a controlled setting without direct exogenous GH administration.

Adverse Signals Documented in Investigational Data

•       Increased appetite — documented in both animal models and the human clinical trial literature
•       Fluid retention — observed in some human investigational data
•       Potential insulin resistance signals in animal models at extended administration periods
•       SST (somatostatin) upregulation observed with prolonged administration in animal models, potentially attenuating GH stimulation over time

What Are the Risks and Limitations of MK-677 (Ibutamoren) Research?

This section is mandatory reading before working with MK-677 in any laboratory setting.

Handling Precautions

MK-677 should be handled by trained laboratory personnel in a controlled research environment. Use appropriate PPE. Handle capsule formulations with care to avoid dust inhalation.

Exposure Risks

MK-677 is an orally active GHSR-1a agonist with documented GH and IGF-1 pathway effects in preclinical and limited human investigational data. No approved human safety data for chronic use exists.

Storage

Store MK-677 at room temperature in a dry, sealed environment away from light and moisture.

Toxicity and Data Limitations

No chronic toxicity data exist specific to MK-677 as a research compound. All body composition and hormonal findings are from animal models or short-duration human investigational contexts.

GH/IGF-1 Axis Downstream Effects

Sustained GHSR-1a activation in animal models is associated with somatostatin upregulation that may attenuate GH secretion over time. Researchers should factor this into extended study designs.

Conclusion

MK-677 has been investigated as a GHSR-1a agonist that, in preclinical models and limited human investigational settings, has been observed to elevate GH and IGF-1 levels. It is a useful probe compound for GH/IGF-1 axis research due to its oral bioavailability. However, despite documented target engagement, clinical trials have not demonstrated therapeutic benefit in the conditions studied. MK-677 is not approved for human use and must only be used in properly supervised, IACUC-compliant laboratory research settings.

MK-677 is available for sale at BehemothLabz for licensed laboratory research use only. Each batch is independently third-party tested, and a Certificate of Analysis (COA) is available per batch. Not for human or veterinary use.

FAQs

What hormones has MK-677 been observed to modulate in preclinical models?

Preclinical investigational data and published investigational literature document that MK-677 has been observed to elevate GH and IGF-1 through GHSR-1a activation. Target engagement (IGF-1 elevation) was documented in a published investigational study, though no therapeutic benefit was demonstrated in that study. MK-677 is not approved for any clinical use.

Is MK-677 a peptide?

No. MK-677 is a non-peptide small molecule with a sulfonamide backbone. This structural characteristic allows oral bioavailability in preclinical settings, distinguishing it from peptide-based secretagogues.

Is MK-677 FDA-approved?

No. MK-677 is not approved by the FDA for any human or veterinary use. It is available strictly as a research compound for laboratory settings.

What adverse signals have been documented in investigational data for MK-677?

Documented adverse signals in investigational data include increased appetite, fluid retention, potential insulin resistance signals at extended administration in animal models, and somatostatin upregulation with prolonged use.

Where can I buy MK-677 for research?

BehemothLabz offers MK-677 (Ibutamoren) capsules for sale for laboratory research purposes only. Each batch is independently third-party tested, with a COA available per batch.

ATTENTION — BehemothLabz Research Compound Notice

All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. Not for human or veterinary use. Contact support@behemothlabz.com with any product concerns.

References

•       Sevigny JJ, Ryan JM, van Dyck CH, et al. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology. 2008;71(21):1702–1708. https://pubmed.ncbi.nlm.nih.gov/19015485/
•       Chapman IM, Bach MA, Van Cauter E, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 1996;81(12):4249–4257. https://pubmed.ncbi.nlm.nih.gov/8954023/